GWM
TNDM icon

Gilpin Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Gilpin Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136 Sell
9
-3
-25% -$52 ﹤0.01% 993
2026
Q1 		$231 Buy
12
+7
+140% +$152 ﹤0.01% 828
2025
Q4 		$110 Buy
+5
New +$90 ﹤0.01% 812

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Gilpin Wealth Management's TNDM Position: Q2 2026 in Review

Gilpin Wealth Management reduced its Tandem Diabetes Care (TNDM) stake by 25% in Q2 2026, selling an estimated $52 and leaving 9 shares worth $136. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Gilpin Wealth Management first reported a position in TNDM in Q4 2025 and has held it in 3 quarters since. The position peaked at $231 in Q1 2026. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Gilpin Wealth Management held 9 shares of Tandem Diabetes Care worth $136 as of Q2 2026.
  • Gilpin Wealth Management sold 3 Tandem Diabetes Care shares in Q2 2026, an estimated $52.
  • Tandem Diabetes Care made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #993 holding.
  • Gilpin Wealth Management first reported a position in Tandem Diabetes Care in Q4 2025 and has held it in 3 quarters since.
  • Gilpin Wealth Management's Tandem Diabetes Care position peaked at $231 in Q1 2026.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.